Renal transplant biopsy

What does it tell?

Kim Solez, Marjan Afrouzian, Nestor Pakasa, Kazuhito Takeda, Kiril Trpkov

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

The value of the renal allograft biopsy has been significantly enhanced by several developments in 1997 including the following: the first convincing demonstration that molecular biology techniques can be applied to renal allograft tissue to obtain a diagnosis of acute rejection with high sensitivity and specificity; the development of an improved, internationally agreed classification of kidney transplantation pathology ('Banff 1997'); and significant new insights into the specific pathology of chronic rejection, involving splitting and lamination of peritubular capillary basement membranes and the presence of increased apoptotic cell death. Although it is predictable that long-term technology might eliminate the need for renal allograft biopsies altogether, in the short term these new breakthroughs will greatly increase the value of this procedure in the management of renal transplant patients.

Original languageEnglish (US)
Pages (from-to)538-543
Number of pages6
JournalCurrent Opinion in Nephrology and Hypertension
Volume6
Issue number6
StatePublished - 1997
Externally publishedYes

Fingerprint

Allografts
Transplants
Kidney
Biopsy
Pathology
Basement Membrane
Kidney Transplantation
Molecular Biology
Cell Death
Technology
Sensitivity and Specificity

ASJC Scopus subject areas

  • Nephrology
  • Internal Medicine

Cite this

Solez, K., Afrouzian, M., Pakasa, N., Takeda, K., & Trpkov, K. (1997). Renal transplant biopsy: What does it tell? Current Opinion in Nephrology and Hypertension, 6(6), 538-543.

Renal transplant biopsy : What does it tell? / Solez, Kim; Afrouzian, Marjan; Pakasa, Nestor; Takeda, Kazuhito; Trpkov, Kiril.

In: Current Opinion in Nephrology and Hypertension, Vol. 6, No. 6, 1997, p. 538-543.

Research output: Contribution to journalArticle

Solez, K, Afrouzian, M, Pakasa, N, Takeda, K & Trpkov, K 1997, 'Renal transplant biopsy: What does it tell?', Current Opinion in Nephrology and Hypertension, vol. 6, no. 6, pp. 538-543.
Solez, Kim ; Afrouzian, Marjan ; Pakasa, Nestor ; Takeda, Kazuhito ; Trpkov, Kiril. / Renal transplant biopsy : What does it tell?. In: Current Opinion in Nephrology and Hypertension. 1997 ; Vol. 6, No. 6. pp. 538-543.
@article{464bdf5be26946a3850a9f2f44ef0bdd,
title = "Renal transplant biopsy: What does it tell?",
abstract = "The value of the renal allograft biopsy has been significantly enhanced by several developments in 1997 including the following: the first convincing demonstration that molecular biology techniques can be applied to renal allograft tissue to obtain a diagnosis of acute rejection with high sensitivity and specificity; the development of an improved, internationally agreed classification of kidney transplantation pathology ('Banff 1997'); and significant new insights into the specific pathology of chronic rejection, involving splitting and lamination of peritubular capillary basement membranes and the presence of increased apoptotic cell death. Although it is predictable that long-term technology might eliminate the need for renal allograft biopsies altogether, in the short term these new breakthroughs will greatly increase the value of this procedure in the management of renal transplant patients.",
author = "Kim Solez and Marjan Afrouzian and Nestor Pakasa and Kazuhito Takeda and Kiril Trpkov",
year = "1997",
language = "English (US)",
volume = "6",
pages = "538--543",
journal = "Current Opinion in Nephrology and Hypertension",
issn = "1062-4821",
publisher = "Lippincott Williams and Wilkins",
number = "6",

}

TY - JOUR

T1 - Renal transplant biopsy

T2 - What does it tell?

AU - Solez, Kim

AU - Afrouzian, Marjan

AU - Pakasa, Nestor

AU - Takeda, Kazuhito

AU - Trpkov, Kiril

PY - 1997

Y1 - 1997

N2 - The value of the renal allograft biopsy has been significantly enhanced by several developments in 1997 including the following: the first convincing demonstration that molecular biology techniques can be applied to renal allograft tissue to obtain a diagnosis of acute rejection with high sensitivity and specificity; the development of an improved, internationally agreed classification of kidney transplantation pathology ('Banff 1997'); and significant new insights into the specific pathology of chronic rejection, involving splitting and lamination of peritubular capillary basement membranes and the presence of increased apoptotic cell death. Although it is predictable that long-term technology might eliminate the need for renal allograft biopsies altogether, in the short term these new breakthroughs will greatly increase the value of this procedure in the management of renal transplant patients.

AB - The value of the renal allograft biopsy has been significantly enhanced by several developments in 1997 including the following: the first convincing demonstration that molecular biology techniques can be applied to renal allograft tissue to obtain a diagnosis of acute rejection with high sensitivity and specificity; the development of an improved, internationally agreed classification of kidney transplantation pathology ('Banff 1997'); and significant new insights into the specific pathology of chronic rejection, involving splitting and lamination of peritubular capillary basement membranes and the presence of increased apoptotic cell death. Although it is predictable that long-term technology might eliminate the need for renal allograft biopsies altogether, in the short term these new breakthroughs will greatly increase the value of this procedure in the management of renal transplant patients.

UR - http://www.scopus.com/inward/record.url?scp=0030785087&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030785087&partnerID=8YFLogxK

M3 - Article

VL - 6

SP - 538

EP - 543

JO - Current Opinion in Nephrology and Hypertension

JF - Current Opinion in Nephrology and Hypertension

SN - 1062-4821

IS - 6

ER -